New needle-free nasal vaccine shows promise for COVID-19
New research shows that a needle-free mucosal bacteriophage (phage) T4-based COVID-19 vaccine is effective against SARS-CoV-2 infection. The findings were published in mBio, an open access journal of the American Society for Microbiology.
In recent years, the Food and Drug Administration authorized mRNA- and adenovirus-based SARS-CoV-2 vaccines.
from Breaking World Pharma News https://ift.tt/Mh35ZU6
Comments
Post a Comment